The Biden administration on Tuesday unveiled the first 10 drugs subject to Medicare price negotiations, promising billions of dollars in savings for the federal government and the nine million Medicare beneficiaries taking at least one of the popular medications. Medicare has been banned from directly negotiating lower drug prices since 2003, but the Inflation Reduction…